TickerFacts.

Idexx Laboratories Inc (IDXX): Operating Income

Annual figures by period end, from SEC filings.

$1.36B
Year ended 2025-12-31
$1.46B
Trailing 12 months to 2026-06-30
+14.8%
3-year compound annual growth
+14.4%
5-year compound annual growth
+16.3%
10-year compound annual growth
2008-12-31: $172.46M2009-12-31: $175.97M2010-12-31: $203.88M2011-12-31: $236.22M2012-12-31: $262.56M2013-12-31: $266.76M2014-12-31: $260.25M2015-12-31: $299.91M2016-12-31: $350.24M2017-12-31: $413.03M2018-12-31: $491.33M2019-12-31: $552.85M2020-12-31: $694.52M2021-12-31: $932.03M2022-12-31: $898.76M2023-12-31: $1.10B2024-12-31: $1.13B2025-12-31: $1.36B$1.36B
2008-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$1.36B+20.5%2026-02-20, From 2025-01-01
2024-12-31$1.13B+2.8%2026-02-20, From 2024-01-01
2023-12-31$1.10B+22.1%2026-02-20, From 2023-01-01
2022-12-31$898.76M-3.6%2025-02-21, From 2022-01-01
2021-12-31$932.03M+34.2%2024-02-22, From 2021-01-01
2020-12-31$694.52M+25.6%2023-02-16, From 2020-01-01
2019-12-31$552.85M+12.5%2022-02-16, From 2019-01-01
2018-12-31$491.33M+19.0%2021-02-12, From 2018-01-01
2017-12-31$413.03M+17.9%2020-02-14, From 2017-01-01
2016-12-31$350.24M+16.8%2019-02-15, From 2016-01-01
2015-12-31$299.91M+15.2%2018-02-16, From 2015-01-01
2014-12-31$260.25M-2.4%2017-02-17, From 2014-01-01
2013-12-31$266.76M+1.6%2016-02-17, From 2013-01-01
2012-12-31$262.56M+11.1%2015-02-17, From 2012-01-01
2011-12-31$236.22M+15.9%2014-02-18, From 2011-01-01
2010-12-31$203.88M+15.9%2013-02-19, From 2010-01-01
2009-12-31$175.97M+2.0%2012-02-17, From 2009-01-01
2008-12-31$172.46Mn/a2011-02-22, From 2008-01-01

Operating Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Idexx Laboratories Inc (IDXX)2025-12-31$1.36B+20.5%
QuidelOrtho Corp (QDEL)2025-12-28-$919.20Mn/m
Lantheus Holdings, Inc. (LNTH)2025-12-31$310.83M-32.0%
Neogen Corp (NEOG)2026-05-31-$21.60Mn/m
Myriad Genetics Inc (MYGN)2025-12-31-$387.20Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$440.99Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$16.98Mn/m
Immucell Corp (ICCC)2025-12-31$1.65Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.91Mn/m

Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗